Rekah Pharmaceutical Industry Ltd (REKA) — Cash Flow-to-Debt Ratio
Rekah Pharmaceutical Industry Ltd (REKA) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of ILA5.27 Million could theoretically repay 0% of its total liabilities (ILA279.47 Million) in one year. See REKA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Rekah Pharmaceutical Industry Ltd Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for Rekah Pharmaceutical Industry Ltd across 20 annual periods. Also explore REKA net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Rekah Pharmaceutical Industry Ltd (2004–2025)
Year-by-year debt coverage analysis for Rekah Pharmaceutical Industry Ltd. For market capitalisation and broader financial context, see REKA company net worth.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | ILA12.95 Million | ILA279.47 Million | ▼ -50.2% |
| 2024 | 0.09x | ILA26.54 Million | ILA285.24 Million | ▲ +8.0% |
| 2023 | 0.09x | ILA28.35 Million | ILA329.14 Million | ▼ -36.8% |
| 2022 | 0.14x | ILA39.00 Million | ILA286.34 Million | ▲ +69.9% |
| 2021 | 0.08x | ILA21.17 Million | ILA264.02 Million | ▲ +80.6% |
| 2020 | 0.04x | ILA11.28 Million | ILA254.10 Million | ▼ -72.3% |
| 2019 | 0.16x | ILA33.91 Million | ILA211.89 Million | ▲ +38.5% |
| 2018 | 0.12x | ILA17.28 Million | ILA149.62 Million | ▼ -27.0% |
| 2017 | 0.16x | ILA23.80 Million | ILA150.33 Million | ▲ +50.4% |
| 2016 | 0.11x | ILA22.82 Million | ILA216.86 Million | ▲ +262.9% |
| 2015 | 0.03x | ILA5.81 Million | ILA200.17 Million | ▲ +408.3% |
| 2014 | 0.01x | ILA1.33 Million | ILA233.05 Million | ▼ -89.1% |
| 2013 | 0.05x | ILA11.71 Million | ILA223.65 Million | ▼ -16.3% |
| 2012 | 0.06x | ILA14.18 Million | ILA226.90 Million | ▲ +108.1% |
| 2010 | 0.03x | ILA6.73 Million | ILA224.18 Million | ▼ -75.3% |
| 2009 | 0.12x | ILA26.03 Million | ILA214.25 Million | ▲ +328.6% |
| 2008 | 0.03x | ILA6.57 Million | ILA231.87 Million | ▼ -46.7% |
| 2007 | 0.05x | ILA12.45 Million | ILA233.86 Million | ▲ +159.2% |
| 2005 | 0.02x | ILA4.27 Million | ILA208.15 Million | ▼ -82.4% |
| 2004 | 0.12x | ILA17.87 Million | ILA153.18 Million | — |